Embecta Corp. (EMBC)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$5.80+1.93%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · EMBC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 1,018.7 | 1,080.4 | 1,123.1 | 1,120.8 | 1,129.5 | 1,165.3 | 1,085.5 |
| Cost of Revenues | 417.4 | 403.6 | 387.9 | 370.9 | 354.6 | 364.9 | 322.9 |
| Gross Profit | 601.3 | 676.8 | 735.2 | 749.9 | 774.9 | 800.4 | 762.6 |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 319.3 | 332.0 | 365.1 | 341.3 | 294.8 | 240.3 | 214.7 |
| R&D Expenses | 20.2 | 37.3 | 78.8 | 85.2 | 66.9 | 63.3 | 61.4 |
| Other Operating Expenses, Total | 26.4 | (0.7) | — | (1.1) | — | — | — |
| Operating Income | 223.5 | 242.1 | 166.8 | 221.5 | 309.6 | 492.0 | 486.5 |
| Earnings from Continuing Operations | |||||||
| Other Non-Operating Income / Expenses | (1.8) | 1.5 | (10.3) | (8.8) | (6.8) | 2.9 | (0.7) |
| Asset Writedown | — | — | — | 2.5 | 58.9 | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | 125.0 | 136.3 | 44.2 | 105.7 | 256.6 | 494.9 | 485.8 |
| Income Tax Expense | 37.5 | 40.9 | (34.1) | 35.3 | 33.0 | 80.1 | 58.2 |
| Net Income | |||||||
| Net Income | 87.5 | 95.4 | 78.3 | 70.4 | 223.6 | 414.8 | 427.6 |
| Per Share | |||||||
| Basic EPS | 1.50 | 1.64 | 1.36 | 1.23 | 3.92 | 7.28 | 7.50 |
| Diluted EPS | 1.50 | 1.62 | 1.34 | 1.22 | 3.89 | 7.28 | 7.50 |
| Revenue per Share | 17.41 | — | — | — | — | — | — |
| Dividend per Share | — | 0.60 | 0.60 | 0.60 | 0.15 | — | — |
| Basic Weighted Avg Shares | 58.5 | 58.3 | 57.7 | 57.2 | 57.0 | 57.0 | 57.0 |
| Diluted Weighted Avg Shares | 58.5 | 58.9 | 58.3 | 57.8 | 57.5 | 57.0 | 57.0 |
| Supplemental | |||||||
| EBITDA | — | 282.8 | 203.0 | 254.1 | 341.3 | 530.3 | 524.8 |
| EBIT | 223.5 | 242.1 | 166.8 | 221.5 | 309.6 | 492.0 | 486.5 |
| Effective Tax Rate | 30.0% | — | — | 33.4% | 12.9% | 16.2% | 12.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.